NOS3 and necrotizing enterocolitis: There were no differences between eNOS KO and WT groups undergoing NEC alone in clinical sickness scores (p > 0.9999, Figure 7b), macroscopic intestinal injury scores (p = 0.9678, Figure 7c), and histological intestinal injury scores (p > 0.9999, Figure 7d).When comparing outcomes between eNOS KO and WT groups receiving CS supplementation (NEC + CS vs eNOS KO NEC + CS), there were no significant differences in clinical sickness scores (p = 0.9464, Figure 7b), macroscopic intestinal injury scores (p > 0.9999, Figure 7c), or histological intestinal injury scores (p > 0.9999, Figure 7d).